euro adhoc: Disclosure announcement after § 15 WpHG
LION Bioscience AG
Board of Directors (Appointments and Changes)
Supervisory Board of LION bioscience AG Resigns

---------------------------------------------------------------------   Disclosure announcement transmitted by euro adhoc.   The issuer is responsible for the content of this announcement. ---------------------------------------------------------------------

LION bioscience AG, Cambridge, MA, USA, Heidelberg, Germany, October 14, 2004 – LION bioscience (Nasdaq: LEON) today announced that the Supervisory Board of LION bioscience AG, Jürgen Dormann, Prof. Klaus Pohle and Richard Roy stepped down effective immediately after yesterdays Supervisory Board meeting. Due to its NASDAQ listing the company could not extent its Directors & Officers insurance at economically feasible terms.  

The local trade court in Heidelberg will appoint the new Supervisory Board. Dr. Friedrich von Bohlen, a major shareholder of the company, has indicated his support for this process.

end of announcement                                euro adhoc 14.10.2004 09:27:13

Further inquiry note: Günter Dielmann, Tel.: +49 6221 4038-249, Julia Fritz, Tel.: +49 6221 4038-158, Tracy Coffey, Tel.: +1 857 919 9975,

Branche: Pharmaceuticals
ISIN:      DE0005043509
WKN:        504350
Index:    Nemax 50, Prime Standard
Börsen:  Frankfurter Wertpapierbörse / regulated dealing
              New York / regulated dealing
              Berliner Wertpapierbörse / free trade
              Hamburger Wertpapierbörse / free trade
              Baden-Württembergische Wertpapierbörse / free trade
              Börse Düsseldorf / free trade
              Niedersächsische Börse zu Hannover / free trade
              Bayerische Börse / free trade
              Bremer Wertpapierbörse (BWB) / free trade

Weitere Meldungen: SYGNIS AG

Das könnte Sie auch interessieren: